Publikationen, an denen er mitarbeitet Francisco Javier Ballina García (20)

2021

  1. Profiling of Serum Oxylipins During the Earliest Stages of Rheumatoid Arthritis

    Arthritis and Rheumatology, Vol. 73, Núm. 3, pp. 401-413

2020

  1. Glyca levels during the earliest stages of rheumatoid arthritis: Potential use as a biomarker of subclinical cardiovascular disease

    Journal of Clinical Medicine, Vol. 9, Núm. 8, pp. 1-19

2019

  1. IRF4 and IRGS delineate clinically relevant gene expression signatures in systemic lupus erythematosus and rheumatoid arthritis

    Frontiers in Immunology, Vol. 10, Núm. JAN

  2. Vitamin D Receptor Polymorphism and DHCR7 Contribute to the Abnormal Interplay Between Vitamin D and Lipid Profile in Rheumatoid Arthritis

    Scientific Reports, Vol. 9, Núm. 1

2018

  1. Heterogeneity of the type I interferon signature in rheumatoid arthritis: A potential limitation for its use as a clinical biomarker

    Frontiers in Immunology, Vol. 8, Núm. JAN

  2. Profiling of B-Cell Factors and Their Decoy Receptors in Rheumatoid Arthritis: Association With Clinical Features and Treatment Outcomes

    Frontiers in immunology, Vol. 9, pp. 2351

2017

  1. High triglycerides and low high-density lipoprotein cholesterol lipid profile in rheumatoid arthritis: A potential link among inflammation, oxidative status, and dysfunctional high-density lipoprotein

    Journal of Clinical Lipidology, Vol. 11, Núm. 4, pp. 1043-1054.e2

2016

  1. Antibodies to paraoxonase 1 are associated with oxidant status and endothelial activation in rheumatoid arthritis

    Clinical Science, Vol. 130, Núm. 21, pp. 1889-1899

  2. Non-esterified fatty acids profiling in rheumatoid arthritis: Associations with clinical features and Th1 response

    PLoS ONE, Vol. 11, Núm. 8

  3. Paraoxonase 1 Activity Is Modulated by the rs662 Polymorphism and IgG Anti-High-Density Lipoprotein Antibodies in Patients with Rheumatoid Arthritis: Potential Implications for Cardiovascular Disease

    Arthritis and Rheumatology, Vol. 68, Núm. 6, pp. 1367-1376

2015

  1. Altered profile of circulating microparticles in rheumatoid arthritis patients

    Clinical Science, Vol. 128, Núm. 7, pp. 437-448

  2. Angiogenic T cells are decreased in rheumatoid arthritis patients

    Annals of the Rheumatic Diseases, Vol. 74, Núm. 5, pp. 921-927

  3. Antibodies to high-density lipoproteins are associated with inflammation and cardiovascular disease in rheumatoid arthritis patients

    Translational Research, Vol. 166, Núm. 6, pp. 529-539

  4. Good response to tumour necrosis factor alpha blockade results in an angiogenic T cell recovery in rheumatoid arthritis patients

    Rheumatology (United Kingdom)

  5. Red cell distribution width is associated with endothelial progenitor cell depletion and vascular-related mediators in rheumatoid arthritis

    Atherosclerosis, Vol. 240, Núm. 1, pp. 131-136

  6. TNFα polymorphism as marker of immunosenescence for rheumatoid arthritis patients

    Experimental Gerontology, Vol. 61, pp. 123-129

2014

  1. IFNα serum levels are associated with endothelial progenitor cells imbalance and disease features in rheumatoid arthritis patients

    PLoS ONE, Vol. 9, Núm. 1

  2. Red cell distribution width is associated with cardiovascular risk and disease parameters in rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 54, Núm. 4, pp. 641-646

2012

  1. Circulating endothelial cells and their progenitors in systemic lupus erythematosus and early rheumatoid arthritis patients

    Rheumatology (United Kingdom), Vol. 51, Núm. 10, pp. 1775-1784

  2. Effects of glucocorticoid treatment on CD25 -FOXP3 + population and cytokine-producing cells in rheumatoid arthritis

    Rheumatology (United Kingdom), Vol. 51, Núm. 7, pp. 1198-1207